205 related articles for article (PubMed ID: 35212939)
1. Novel Exosome Biomarker Candidates for Alzheimer's Disease Unravelled Through Mass Spectrometry Analysis.
Soares Martins T; Marçalo R; da Cruz E Silva CB; Trindade D; Catita J; Amado F; Melo T; Rosa IM; Vogelgsang J; Wiltfang J; da Cruz E Silva OAB; Henriques AG
Mol Neurobiol; 2022 May; 59(5):2838-2854. PubMed ID: 35212939
[TBL] [Abstract][Full Text] [Related]
2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
3. Exosomal Aβ-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease.
Soares Martins T; Marçalo R; Ferreira M; Vaz M; Silva RM; Martins Rosa I; Vogelgsang J; Wiltfang J; da Cruz E Silva OAB; Henriques AG
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920336
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges.
Lee S; Mankhong S; Kang JH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965555
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
Soares Martins T; Trindade D; Vaz M; Campelo I; Almeida M; Trigo G; da Cruz E Silva OAB; Henriques AG
J Neurochem; 2021 Jan; 156(2):162-181. PubMed ID: 32618370
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.
Dinkins MB; Wang G; Bieberich E
J Alzheimers Dis; 2017; 60(3):757-768. PubMed ID: 27662306
[TBL] [Abstract][Full Text] [Related]
7. Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.
Soares Martins T; Magalhães S; Rosa IM; Vogelgsang J; Wiltfang J; Delgadillo I; Catita J; da Cruz E Silva OAB; Nunes A; Henriques AG
J Alzheimers Dis; 2020; 74(1):391-405. PubMed ID: 32039849
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease.
Jiang L; Dong H; Cao H; Ji X; Luan S; Liu J
Med Sci Monit; 2019 May; 25():3329-3335. PubMed ID: 31056537
[TBL] [Abstract][Full Text] [Related]
9. Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
Arioz BI; Tufekci KU; Olcum M; Durur DY; Akarlar BA; Ozlu N; Bagriyanik HA; Keskinoglu P; Yener G; Genc S
Neurosci Lett; 2021 Jun; 755():135914. PubMed ID: 33901610
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids.
Vaz M; Soares Martins T; Henriques AG
J Neurochem; 2022 Nov; 163(4):266-309. PubMed ID: 36156258
[TBL] [Abstract][Full Text] [Related]
11. Exosomal biomarkers in Down syndrome and Alzheimer's disease.
Hamlett ED; Ledreux A; Potter H; Chial HJ; Patterson D; Espinosa JM; Bettcher BM; Granholm AC
Free Radic Biol Med; 2018 Jan; 114():110-121. PubMed ID: 28882786
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles in Alzheimer's and Parkinson's Disease: Small Entities with Large Consequences.
Vandendriessche C; Bruggeman A; Van Cauwenberghe C; Vandenbroucke RE
Cells; 2020 Nov; 9(11):. PubMed ID: 33203181
[TBL] [Abstract][Full Text] [Related]
13. FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
Soares Martins T; Ferreira M; Magalhães S; Leandro K; Almeida LP; Vogelgsang J; Breitling B; Hansen N; Esselmann H; Wiltfang J; da Cruz E Silva OAB; Nunes A; Henriques AG
J Alzheimers Dis; 2024; 98(3):1157-1167. PubMed ID: 38489187
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression.
Aharon A; Spector P; Ahmad RS; Horrany N; Sabbach A; Brenner B; Aharon-Peretz J
Mol Neurobiol; 2020 Oct; 57(10):4156-4169. PubMed ID: 32676990
[TBL] [Abstract][Full Text] [Related]
15. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer's Disease.
Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Ali SF; Hanig J; Sarkar S
Curr Alzheimer Res; 2019; 16(5):388-395. PubMed ID: 30907317
[TBL] [Abstract][Full Text] [Related]
17. Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Kim KY; Shin KY; Chang KA
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356604
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β protein and MicroRNA-384 in NCAM-Labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer's disease.
Li Y; Meng S; Di W; Xia M; Dong L; Zhao Y; Ling S; He J; Xue X; Chen X; Liu C
CNS Neurosci Ther; 2022 Jul; 28(7):1093-1107. PubMed ID: 35470961
[TBL] [Abstract][Full Text] [Related]
19. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
20. Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteome.
Erozenci LA; Böttger F; Bijnsdorp IV; Jimenez CR
FEBS Lett; 2019 Jul; 593(13):1580-1597. PubMed ID: 31198995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
